Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-002321

Options or other derivatives

  • Director acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Unanue Peter · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-29 Grant or award : show line 1 in the form Series A Preferred Stock +50,000 $93,750.00 $4,687,500,000 50,000 D
2018-03-29 Grant or award : show line 2 in the form Warrant +50,000 $6,250.00 $312,500,000 50,000 D
Loading xslF345X03/s109515_form4.xml…